Quantcast

Latest Naloxone Stories

2014-09-16 08:32:01

Big Cities Health Coalition Urges Immediate Federal Action WASHINGTON, Sept. 16, 2014 /PRNewswire/ -- Today, the top public health officials from Boston, Chicago, and New York City, all members of the Big Cities Health Coalition, arrived on Capitol Hill with a grim report on the state of opioid addiction and overdose in our nation's cities - and a request for federal action to be taken immediately. "Opioid addiction is one of the most challenging problems for health departments to...

2014-09-03 08:32:49

September 4th ceremony celebrates 2014 accomplishments including FDA approval and anticipated commercial launch of BUNAVAIL RALEIGH, N.C., Sept. 3, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that the company will visit the NASDAQ MarketSite in Times Square on September 4, 2014. In honor of the occasion, Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will ring the opening bell for the trading session that day....

2014-08-31 23:01:19

Harbor Village Florida Comments on New Street Drug Showing to be Much More Powerful Than Heroin USA (PRWEB) August 31, 2014 According to an article posted in Medical News Today (8/21), entitled Emerging Street Drug Fifteen Times Stronger than Heroin, a new opiate has begun to hit the streets of America which is fifteen times more potent than heroin. Known as acetyl fentanyl, this opiate is a non-medical use drug that has been linked to many overdoses and emergency room visits among opiate...

2014-08-27 08:27:45

RALEIGH, N.C., Aug. 27, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that the company will be hosting an investor and analyst event and simultaneous webcast on Friday, September 5, 2014. The event is scheduled for 12-2 pm ET in New York City. http://photos.prnewswire.com/prnvar/20110217/CL49801LOGO At this event, BDSI senior management will discuss the commercialization and launch plan for BUNAVAIL and provide updates on the BEMA(®)...

2014-08-07 16:29:42

BUNAVAIL(TM) (buprenorphine and naloxone) buccal film (CIII) approved by FDA for the maintenance treatment of opioid dependence; US launch planned for late Q3 RALEIGH, N.C., Aug. 7, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that it has filed its Quarterly Report on Form 10-Q for the quarter ended June 30, 2014 with the U.S. Securities and Exchange Commission and, in connection therewith, is providing a review of BDSI's recent achievements and an...

2014-07-30 23:15:52

Mental Health Center at the Cedars-Sinai Medical Towers becomes the first medical practice in Los Angeles to distribute free prescription Naloxone to local treatment centers and sober living facilities. Beverly Hills, CA (PRWEB) July 30, 2014 On January 1, 2014, the Overdose Treatment Act (AB 635) became law in California. The law allows lay people to possess and administer prescription naloxone to someone in urgent need who is experiencing life-threatening respiratory depression from an...

2014-07-30 08:33:40

LONDON, July 30, 2014 /PRNewswire/ -- Lightlake Therapeutics Inc. ("Lightlake") (OTCQB: LLTP), a biopharmaceutical company developing addiction treatments based on its expertise in opioid antagonists, announced today that it has received a funding commitment from a prominent international research and development foundation. The foundation has a focus on promoting innovative research-based initiatives, including those addressing health issues. Lightlake has been developing a nasal...

2014-07-23 08:31:41

LONDON, July 23, 2014 /PRNewswire/ -- Lightlake Therapeutics Inc. ("Lightlake") (OTCQB: LLTP), a biopharmaceutical company developing addiction treatments based on its expertise in opioid antagonists, announced today that it has filed an investigational new drug application ("IND") with respect to its naloxone-based opioid overdose reversal nasal spray. Lightlake also announced today that it has received an additional commitment from the National Institute on Drug Abuse ("NIDA"), part...

2014-07-22 08:31:15

RALEIGH, N.C., July 22, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (BDSI) (NASDAQ: BDSI) announced that its Board of Directors has appointed Charles J. (Chuck) Bramlage and Dr. Barry I. Feinberg as members of the Board. http://photos.prnewswire.com/prnvar/20110217/CL49801LOGO Mr. Bramlage is a veteran pharmaceutical industry executive with extensive experience in marketing, sales and other commercial functions. He is currently the Chief Executive Officer of...

2014-07-11 23:04:58

Harbor Village Florida comments how citizens of New Jersey are receiving training on how to administer opiate-overdose reversal drug Narcan. Ocean County, NJ (PRWEB) July 11, 2014 As reported by the Star Ledger in the article Officials To Give Out 100 Free Narcan Kits in Ocean County (7/3), 100 residents of Ocean County in New Jersey recently received free training on how to administer the drug Narcan, an opiate-overdose reversal drug as well as a free kit during this previous Fourth of...


Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.